Proteomic and in silico dissection of MetaAggregates in amyotrophic lateral sclerosis brains
Kazuma MurakamiiD, Thi Hong Van NguyeniD, Nobuko Fujita, Chioko NagaoiD, Kenji MizuguchiiD, Takumi NishiuchiiD, Yasuhiro SakashitaiD, Moeko Noguchi‐ShinoharaiD, Kenjiro OnoiD
Abstract
RNA-binding proteins (RBPs), key translation regulators, are thought to be involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). The pathological entities associated with ALS are known as "MetaAggregates": heterogeneous coaggregates composed of amyloids, RBPs, and RNA G-quadruplexes (rG4s). In this study, to explore the molecular constituents of ALS-associated MetaAggregates, we developed a proteomic approach using a psoralen-conjugated RBP and crosslinked it with a biotinylated rG4 to enable the isolation of MetaAggregates from ALS brain extracts. Single-cell RNA-seq using in vitro ALS models identified ELAVL4 as a cytoplasmic RBP and revealed the enrichment of an IGFBP2-derived rG4 structure in ALS-specific neurons. Mass spectrometry and amyloidogenicity-based principal component analysis revealed 79 candidate proteins with roles in RNA processing, metabolism, trafficking, and stress responses. Docking simulations highlighted a subset of proteins with potential pro-aggregation characteristics, diverse cytosolic associations and functional links to RNA processing relevant to ALS. Through proteomic and in silico dissection of ALS-associated MetaAggregates, the findings of this study establish a conceptual framework for the exploration of unrecognized amyloidogenic drivers of neurodegeneration.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Analysis of circulating protein aggregates reveals pathological hallmarks of amyotrophic lateral sclerosis
Rocco Adiutori, Fabìola Puentes, … Andrea Malaspina·bioRxiv·Apr 30, 2020
- Targeting FUS-ALS aggregation with Proteasome Inhibitors
Amal Younis, Kanar Yassen, … Reut Shalgi·bioRxiv·Sep 17, 2024
- The accumulation of orphan ribosomal proteins is a hallmark of ALS
Anabel Sáez-Mas, Guillermo de la Vega-Barranco, … Óscar Fernández-Capetillo·bioRxiv·May 19, 2026
- A transient protein folding response targets aggregation in the early phase of TDP-43-mediated disease
Rebecca San Gil, Dana Pascovici, … Adam K. Walker·bioRxiv·Jun 21, 2023
- ALS-associated RNA binding proteins converge on UNC13A transcription through regulation of REST
Yasuaki Watanabe, Naoki Suzuki, … Keiko Nakayama·bioRxiv·Oct 22, 2024
- Microglial activation in an amyotrophic lateral sclerosis-like model caused by Ranbp2 lossand nucleocytoplasmic transport impairment in retinal ganglion neurons
Kyoungin Cho, Dosuk Yoon, … Paulo A. Ferreira·Cellular and Molecular Life SciencesPeer-reviewed·Apr 3, 2019